Anpario (LSE:ANP) delivered a strong performance in 2025, reporting revenue growth of 24% to £47.2m while profit before tax rose 54% to £8.0m. The results were supported by improved gross margins and solid cash generation across the business.
Growth during the year was driven in part by the first full-year contribution from U.S.-based Bio-Vet, alongside 12% like-for-like sales growth across Anpario’s existing operations. The company also benefited from strong demand for its higher-margin natural feed additives across key markets in the Americas, Europe and Asia.
The improved financial performance allowed the group to increase its total dividend by 11%, reflecting confidence in the strength of its cash flow and long-term growth strategy. Management highlighted that the results reinforce Anpario’s shift toward premium, sustainable animal nutrition products, even as the business navigates ongoing geopolitical and logistical challenges affecting global supply chains.
From an investment perspective, Anpario’s outlook is supported by strong financial performance and positive corporate developments. Technical indicators also suggest a favourable trend, while the company’s valuation appears reasonable relative to its growth profile. The absence of additional earnings call details does not materially affect the overall positive outlook.
More about Anpario
Anpario plc is an independent producer of natural and sustainable feed additives designed to improve animal health, nutrition and biosecurity in global agricultural markets. The company’s product portfolio includes higher value-added solutions such as Orego-Stim and Optomega Algae, which target improved animal performance and welfare. Anpario has also expanded its presence in the United States and broadened its species coverage through the acquisition of Bio-Vet Inc.
Leave a Reply